pyrroles has been researched along with Endometrioma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appleyard, CB; Gorabi, V; Rana, M; Rivera-Lopez, LL; Torres-Reverón, A | 1 |
| Appleyard, CB; Flores, I; Rivera-Lopez, LL; Torres-Reverón, A | 1 |
| Abbas, MA; Disi, AM; Taha, MO | 1 |
| Gul, M; Ozerol, E; Ozerol, IH; Parlakpinar, H; Simsek, Y; Yilmaz, E | 1 |
| Akman, L; Akman, T; Artunc Ulkumen, B; Erbas, O; Oltulu, F; Pala, EE; Pala, HG; Yavasoglu, A | 1 |
| Akkar, OB; Cetin, A; Kacan, SB; Kacan, T; Karakus, S; Ozer, H; Yildiz, C | 1 |
| Dhaliwal, LK; Dhawan, V; Mahajan, N; Saha, SC; Sharma, I | 1 |
| Aksakal, O; Aksoy, Y; Gungor, T; Kilic, S; Lordlar, N; Ozat, M; Sut, N; Yilmaz, B | 1 |
| Elitzsch, A; Laschke, MW; Menger, MD; Vajkoczy, P; Vollmar, B | 1 |
| Bayraktar, N; Eroglu, D; Esinler, I; Haberal, N; Oktem, M; Zeyneloglu, HB | 1 |
10 other study(ies) available for pyrroles and Endometrioma
| Article | Year |
|---|---|
Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis.
Topics: Adrenal Glands; Animals; Disease Models, Animal; Endometriosis; Female; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Rats; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Up-Regulation | 2020 |
Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis.
Topics: Animals; Disease Models, Animal; Disease Progression; Endometriosis; Female; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Treatment Outcome | 2018 |
Sunitinib as an anti-endometriotic agent.
Topics: Animals; Apoptosis; Endometriosis; Endometrium; Epithelial Cells; Female; In Situ Nick-End Labeling; Indoles; Protein Kinase Inhibitors; Pyrroles; Rats; Sunitinib | 2013 |
Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in a rat endometriosis model.
Topics: Analgesics; Animals; Atorvastatin; C-Reactive Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Endometrium; Female; Heptanoic Acids; Humans; Leuprolide; Nociception; Nociceptive Pain; Pyrroles; Rats; Rats, Wistar; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
The effects of sunitinib on endometriosis.
Topics: Angiogenesis Inhibitors; Animals; Danazol; Disease Models, Animal; Endometriosis; Estrogen Antagonists; Female; Indoles; Peritoneal Diseases; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sunitinib; Tissue Adhesions | 2015 |
Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Indazoles; Indoles; Niacinamide; Ovarian Reserve; Phenylurea Compounds; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Rats, Wistar; Signal Transduction; Sorafenib; Sulfonamides; Sunitinib; Vascular Endothelial Growth Factor A | 2015 |
In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
Topics: Adolescent; Adult; Atorvastatin; Biopsy; Case-Control Studies; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin-Like Growth Factor Binding Protein 1; Lipopolysaccharides; Liver X Receptors; Orphan Nuclear Receptors; PPAR gamma; Pyrroles; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins; S100A12 Protein; Stromal Cells; Uterine Diseases; Vascular Endothelial Growth Factor A; Young Adult | 2010 |
Atorvastatin causes regression of endometriotic implants in a rat model.
Topics: Animals; Antioxidants; Atorvastatin; Disease Models, Animal; Endometriosis; Endometrium; Female; Heptanoic Acids; Pyrroles; Rats; Rats, Wistar | 2010 |
Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Topics: Angiogenesis Inhibitors; Animals; Capillaries; Cricetinae; Endometriosis; Endometrium; Female; Fibroblast Growth Factors; Indoles; Mesocricetus; Neovascularization, Pathologic; Oxindoles; Platelet-Derived Growth Factor; Propionates; Protein Kinase Inhibitors; Pyrroles; Uterine Diseases; Vascular Endothelial Growth Factor A | 2006 |
High-dose atorvastatin causes regression of endometriotic implants: a rat model.
Topics: Animals; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Heptanoic Acids; Leuprolide; Pyrroles; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2007 |